Adage Capital Partners
HRMY icon

Adage Capital Partners’s Harmony Biosciences HRMY Stock Holding History

Adage Capital Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-84,000
Closed -$3.14M – 1012
2025
Q4 		$3.14M Buy
+84,000
New +$2.76M ﹤0.01% 807
2025
Q2 		– Sell
-168,000
Closed -$5.58M – 892
2025
Q1 		$5.58M Sell
168,000
-332,000
-66% -$11.9M 0.01% 683
2024
Q4 		$17.2M Buy
500,000
+200,000
+67% +$6.87M 0.03% 475
2024
Q3 		$12M Buy
300,000
+250,000
+500% +$8.78M 0.02% 576
2024
Q2 		$1.51M Sell
50,000
-25,000
-33% -$752K ﹤0.01% 790
2024
Q1 		$2.52M Sell
75,000
-25,000
-25% -$802K ﹤0.01% 764
2023
Q4 		$3.23M Sell
100,000
-1,320,000
-93% -$36.8M 0.01% 720
2023
Q3 		$46.5M Buy
1,420,000
+220,000
+18% +$7.64M 0.11% 211
2023
Q2 		$42.2M Sell
1,200,000
-215,000
-15% -$7.42M 0.09% 223
2023
Q1 		$46.2M Buy
1,415,000
+1,285,000
+988% +$58.5M 0.1% 226
2022
Q4 		$7.16M Sell
130,000
-460,000
-78% -$25.3M 0.02% 707
2022
Q3 		$26.1M Sell
590,000
-444,450
-43% -$21.7M 0.06% 335
2022
Q2 		$50.5M Sell
1,034,450
-97,766
-9% -$4.4M 0.12% 185
2022
Q1 		$55.1M Sell
1,132,216
-617,784
-35% -$25.2M 0.1% 191
2021
Q4 		$74.6M Buy
1,750,000
+509,585
+41% +$20.3M 0.13% 159
2021
Q3 		$47.5M Buy
+1,240,415
New +$39.9M 0.09% 222

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Adage Capital Partners's HRMY Position: Q1 2026 in Review

Adage Capital Partners sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 84,000 shares — an estimated $3.14M sold.

Adage Capital Partners first reported a position in HRMY in Q3 2021 and held it in 16 quarters. The position peaked at $74.6M in Q4 2021. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Adage Capital Partners reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Adage Capital Partners sold 84,000 Harmony Biosciences shares in Q1 2026, an estimated $3.14M.
  • Adage Capital Partners first reported a position in Harmony Biosciences in Q3 2021 and held it in 16 quarters.
  • Adage Capital Partners's Harmony Biosciences position peaked at $74.6M in Q4 2021.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.